The Myeloma Infoline and Ask The Nurse services are fully staffed and are here to answer your questions and concerns and be a listening ear.

You can also visit our dedicated COVID-19 Information Hub for the latest information.


Introducing our new chief executive

Myeloma UK news // 24th April 2020

Laura Kerby will join Myeloma UK from the start of May as Chief Executive, working with the Board, Executive Leadership Team, and the whole organisation to continue to make sure the voices of patients with myeloma and related conditions are heard.

Laura joins from Penny Brohn UK, a national cancer care centre based in Bristol, and brings with her a wealth of experience in ensuring that the needs of cancer patients are recognised and met. Having spent her career working in health and wellbeing, Laura is ready to get started:

“Whilst I would have wished for different circumstances for my start, I am delighted to be able to bring my experience in cancer care and patient experience to Myeloma UK.

The COVID-19 pandemic has required all myeloma patients to follow shielding measures and exacerbated the difficulties that people with myeloma face every day. Demand for Myeloma UK support and information services has almost quadrupled since the pandemic began, making the assistance and representation we provide more crucial than ever.

But it’s vital that patients and their families know that that they can still get in touch with us. We’re up and running and we have the capacity to help you. I know the difference a conversation can make to someone who is anxious and feeling isolated or worried about new symptoms. Staying in touch with Myeloma UK and with your clinical team is incredibly important – We’re all here to support you.

My focus is not only on getting through COVID-19, but on being ready to step up and represent the patient voice as clinical trials and treatment appraisals start up again. Our patients need our support now and throughout the coming months, and I am committed to doing everything to help them and their families live better and for longer with myeloma.”

We’ll be learning more about Laura in the coming weeks, but if you have a question for her, why not let us know by emailing